These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6847492)

  • 1. Adult fluoride therapy for ostosclerosis (otospongiosis).
    Shambaugh GE
    Arch Otolaryngol; 1983 May; 109(5):353. PubMed ID: 6847492
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal absorption of fluoride preparations.
    Deka RC; Kacker SK; Shambaugh GE
    Laryngoscope; 1978 Dec; 88(12):1918-21. PubMed ID: 732493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymology of otospongiosis and NaF therapy.
    Causse JR; Shambaugh GE; Causse B; Bretlau P
    Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of conservative treatment of otosclerosis by endoaural electrophoresis of fluorine preparations and ascorbic acid].
    Gukovich VA; Avramenko LV; Martyniuk LA
    Zh Ushn Nos Gorl Bolezn; 1977; (2):21-8. PubMed ID: 855459
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensorineural deafness due to cochlear otospongiosis: pathogenesis, clinical diagnosis, and therapy.
    Shambaugh GE
    Otolaryngol Clin North Am; 1978 Feb; 11(1):135-54. PubMed ID: 662341
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation.
    Derks W; De Groot JA; Raymakers JA; Veldman JE
    Acta Otolaryngol; 2001 Jan; 121(2):174-7. PubMed ID: 11349772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium fluoride and cochlear otospongiosis.
    Donaldson JA
    Arch Otolaryngol; 1977 Jun; 103(6):313. PubMed ID: 869760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sodium fluoride and otospongiosis].
    Bébéar JP; Hédreville R
    Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):221-5. PubMed ID: 897403
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sodium fluoride, calcium carbonate, and vitamin D on the skeleton in multiple myeloma.
    Kyle RA; Jowsey J
    Cancer; 1980 Apr; 45(7):1669-74. PubMed ID: 6989479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.
    Schiff T; Mateo LR; Delgado E; Cummins D; Zhang YP; DeVizio W
    J Clin Dent; 2011; 22(4):128-38. PubMed ID: 22403989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of otospongiosis.
    Shambaugh GE
    Acta Otorhinolaryngol Belg; 1981; 35(5-6):390-403. PubMed ID: 7347082
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis).
    Causse J; Chevance LG; Shambaugh GE
    Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470
    [No Abstract]   [Full Text] [Related]  

  • 13. Otospongiosis and sodium fluoride. A clinical double-blind, placebo-controlled study on sodium fluoride treatment in otospongiosis.
    Bretlau P; Salomon G; Johnsen NJ
    Am J Otol; 1989 Jan; 10(1):20-2. PubMed ID: 2655462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations.
    Erlacher L; Teufelsbauer H; Bernecker P; Pietschmann P; Weissel M
    Clin Investig; 1994 Dec; 72(12):1082-5. PubMed ID: 7711420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark commercial desensitizing toothpaste containing 2% potassium ion: an eight-week clinical study in Rome, Italy.
    Docimo R; Montesani L; Maturo P; Costacurta M; Bartolino M; Zhang YP; DeVizio W; Delgado E; Cummins D; Dibart S; Mateo LR
    J Clin Dent; 2009; 20(4):137-43. PubMed ID: 19831167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium fluoride therapy.
    Causse JR; Causse JB; Uriel J; Berges J; Shambaugh GE; Bretlau P
    Am J Otol; 1993 Sep; 14(5):482-90. PubMed ID: 8122713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a commercial sensitive toothpaste containing 2% potassium ion: an eight-week clinical study on Canadian adults.
    Ayad F; Ayad N; Zhang YP; DeVizio W; Cummins D; Mateo LR
    J Clin Dent; 2009; 20(1):10-6. PubMed ID: 19489187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Production and clinical study of sodium fluoride tablets in the treatment of otosclerosis].
    Nidzović Z; Macić I; Bodiroga M; Mogorović M; Ivanović A
    Vojnosanit Pregl; 1990; 47(5):352-4. PubMed ID: 2288111
    [No Abstract]   [Full Text] [Related]  

  • 19. [Method of treatment of otosclerosis in its active stage by the endaural sodium fluoride and ascorbic acid electrophoresis].
    Gukovich VA; Martyniuk LA; Abramenko LV
    Zh Ushn Nos Gorl Bolezn; 1978; (2):70-2. PubMed ID: 654557
    [No Abstract]   [Full Text] [Related]  

  • 20. Otospongiosis and sodium fluoride. A blind experimental and clinical evaluation of the effect of sodium fluoride treatment in patients with otospongiosis.
    Bretlau P; Causse J; Causse JB; Hansen HJ; Johnsen NJ; Salomon G
    Ann Otol Rhinol Laryngol; 1985; 94(2 Pt 1):103-7. PubMed ID: 3888030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.